Atopic dermatitis is a common chronic genetically determined skin disease with complex pathogenesis. Due to the high prevalence of dermatosis and its progression to severe forms, the issue of new treatment options for this disease is relevant. This review discusses new current treatment options for atopic dermatitis, targeted drugs that allow patients with poorly controlled moderate to severe atopic dermatitis to achieve disease control.

Keywords: skin itching, upadacitinib, dupilumab, atopic dermatitis, therapy